Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry
about
Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarctionGuidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of CardiologyCardiac power parameters during hypovolemia, induced by the lower body negative pressure technique, in healthy volunteersSeverity of cardiac impairment in the early stage of community-acquired sepsis determines worse prognosis.Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline.Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications.Haemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study.Left-ventricular power-to-mass ratio at peak exercise predicts mortality, heart failure, and cardiovascular events in patients with stable coronary artery disease: data from the Heart and Soul Study.Muscle metaboreflex-induced coronary vasoconstriction functionally limits increases in ventricular contractility.A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry.Hypertonic sodium lactate improves fluid balance and hemodynamics in porcine endotoxic shock.Dynamic arterial elastance to predict arterial pressure response to volume loading in preload-dependent patientsThe Prognostic Value of Peak Cardiac Power Output in Chinese Patients with Chronic Heart Failure.Transpulmonary thermodilution (TPTD) before, during and after Sustained Low Efficiency Dialysis (SLED). A Prospective Study on Feasibility of TPTD and Prediction of Successful Fluid Removal.High postoperative blood levels of macrophage migration inhibitory factor are associated with less organ dysfunction in patients after cardiac surgeryIntra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of StabilizationReversible cardiogenic shock caused by atrioventricular junctional rhythm after percutaneous coronary intervention.Prognostic role of cardiac power index in ambulatory patients with advanced heart failure.Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction.Muscle metaboreflex-induced coronary vasoconstriction limits ventricular contractility during dynamic exercise in heart failureArterial pulmonary hypertension in noncardiac intensive care unit.Cardiac contractile reserve parameters are related to prognosis in septic shock.Minimally invasive beat-by-beat monitoring of cardiac power in normal hearts and during acute ventricular dysfunction.Transpulmonary thermodilution-derived cardiac function index identifies cardiac dysfunction in acute heart failure and septic patients: an observational study.A review of cardiogenic shock in acute myocardial infarctionHemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study.Nitric oxide synthase inhibitors in cardiogenic shock: present and future.Hemodynamic Analysis of Pediatric Septic Shock and Cardiogenic Shock Using Transpulmonary Thermodilution.The management of acute pulmonary arterial hypertension.Shock in acute myocardial infarction: the Cape Horn for trials?Percutaneous devices to support the left ventricle.Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.The science behind percutaneous hemodynamic support: a review and comparison of support strategies.Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock.Delayed Care and Mortality Among Women and Men With Myocardial Infarction.Hemodynamic Support Devices for Shock and High-Risk PCI: When and Which One.Women With Cardiogenic Shock Derive Greater Benefit From Early Mechanical Circulatory Support: An Update From the cVAD Registry.Impact of Therapeutic Plasma Exchange on Hemodynamic Parameters in Medical Intensive Care Unit Patients: An Observational Study.Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.Coronary Revascularization in Cardiogenic Shock.
P2860
Q24683044-F9EA138A-857E-47FC-AC48-442FBE9D2393Q28239975-3AB26024-96DB-45C6-B155-2E29526E1218Q28596952-CCF022AC-E4C3-4921-B504-84F59D5CE119Q30317801-80BA6200-6F7C-4000-8BE0-228AFF17C772Q30318082-E06ED8DE-D94D-4EB8-861E-C40DB9FA896EQ30318473-AA23AF33-9695-4B41-BB5F-CEF16723ABE9Q33364276-B7188117-2F88-4519-BE54-C43574F6C7E8Q33492714-741A71BB-8E21-47EE-824E-5C94426EF7A5Q34085480-499C5838-9808-41E7-8171-424F864B1EB4Q34497058-58F0C155-8003-4DD7-B9CC-8343E0592F0FQ34570157-3FCA5772-3D34-46EA-81C4-8ABA1F50C0EDQ35567187-BD767024-06D8-4186-BE35-A082346B02CCQ35903633-5C3848C0-34AE-4D81-8E73-A24BE8C56C77Q35992398-D5F09E96-2279-4F70-86D8-60729B39BC31Q36130973-ABF7C7D8-410B-43AF-984C-5A524F4797B5Q36240491-398EF1C8-E1C4-4BFB-8B38-D126259481C3Q36313688-10EF6FF7-9CBD-4C88-A53B-E078C807C8E0Q36364556-5DE98D09-E9B2-4BFE-887E-D4DD86209219Q36634008-9904A6D5-0845-4DA1-A2B7-0CDE816DEBF5Q36764392-CCCE128B-7E1C-41A3-B32E-D39A127D9216Q37019853-D0D41659-8118-425C-AFCF-DFE65BBE14DEQ37061327-F11467C2-4CC3-4059-A963-BD86DB4BC981Q37339254-4EF49338-CE2C-4C43-BDE6-0689151C8D38Q37360372-F55E4BAB-B52A-4127-8050-5C9EFC65CBBFQ37414794-2796744A-1B50-4848-A3C8-A9E5626435A2Q37443126-0FD0A9E0-048B-4FE9-B428-53282193028EQ37608590-9DDEB05E-C753-4DEA-A305-5E1EE7ACE1BAQ37733613-3262B47E-051B-43AE-8BE2-512C314D6F92Q37766261-5C9A3229-8351-46BB-A9C9-7326AEC1315FQ37770822-824A9AA2-4D96-4ABC-AADA-D6CAC6FD2803Q37949622-8C695118-C02E-4166-A609-6FEEF72DFEB4Q37969891-1043C8CD-8284-40F5-B0FA-BF1A6C5C67A6Q37995138-7AED8317-0E5F-4153-86FB-E384B2D16A15Q38284058-CB098F8D-B847-4831-8F58-8B4E1D8CE60CQ38371275-7B990A0B-0DFC-432E-A2BB-50475BE1738FQ38601021-AF9F68B9-782E-4BBF-8D66-2840BD0700A7Q39733608-F6200874-ABF0-4CD0-8A3E-F8FC78E091D9Q39816469-3D32A0EF-3255-4E1F-98EF-F42935BD34E4Q39833414-69A64CB9-DE34-4105-AAB0-982B8A474767Q40169143-93834FCF-0BF9-4C20-9603-C5F61EA480DF
P2860
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry
description
article
@en
im Juli 2004 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2004
@uk
name
Cardiac power is the strongest ...... from the SHOCK trial registry
@en
Cardiac power is the strongest ...... from the SHOCK trial registry
@nl
type
label
Cardiac power is the strongest ...... from the SHOCK trial registry
@en
Cardiac power is the strongest ...... from the SHOCK trial registry
@nl
prefLabel
Cardiac power is the strongest ...... from the SHOCK trial registry
@en
Cardiac power is the strongest ...... from the SHOCK trial registry
@nl
P2093
P50
P1476
Cardiac power is the strongest ...... from the SHOCK trial registry
@en
P2093
April M Lowe
John G Webb
Rupert Fincke
SHOCK Investigators
Thierry H LeJemtel
Venu Menon
P304
P356
10.1016/J.JACC.2004.03.060
P407
P577
2004-07-01T00:00:00Z